Sommadossi Jean-Pierre
SEC insider (Form 3/4/5 filer). CIK 0001296995. President, CEO, and Chairman at Atea Pharmaceuticals, Inc. (AVIR). 9 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2026. Located in BOSTON, MA.
Companies Sommadossi Jean-Pierre has filed insider reports for
- Atea Pharmaceuticals, Inc. (AVIR): Director, Officer, President, CEO, and Chairman
Sommadossi Jean-Pierre
CIK: 0001296995
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Atea Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Feb 3, 2026AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect300K shares at avg. $1.24$372K - Jan 31, 2026AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect273K shares- - Jan 31, 2026AVIR
Atea Pharmaceuticals, Inc.
Tax PaymentDirect106.1K shares at avg. $4.24$450K - Jan 31, 2025AVIR
Atea Pharmaceuticals, Inc.
AwardDirect99.5K shares- - Jan 31, 2025AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect173.5K shares- - Jan 31, 2025AVIR
Atea Pharmaceuticals, Inc.
Tax PaymentDirect88.6K shares at avg. $3.06$271K - Sep 19, 2024AVIR
Atea Pharmaceuticals, Inc.
SaleIndirect1.8K shares at avg. $4.00$7K - Sep 18, 2024AVIR
Atea Pharmaceuticals, Inc.
SaleIndirect22.2K shares at avg. $4.03$89K - Sep 17, 2024AVIR
Atea Pharmaceuticals, Inc.
SaleIndirect33.9K shares at avg. $4.05$137K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 3, 2026 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 300,000 | $1.24 | $372,000 | Direct |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 272,983 | - | $0 | Direct |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | Tax Payment | 106,093 | $4.24 | $449,834 | Direct |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award | 99,517 | - | - | Direct |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 173,467 | - | - | Direct |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | Tax Payment | 88,601 | $3.06 | $271,119 | Direct |
| Sep 19, 2024 | AVIR Atea Pharmaceuticals, Inc. | Sale | 1,841 | $4.00 | $7,367 | Indirect |
| Sep 18, 2024 | AVIR Atea Pharmaceuticals, Inc. | Sale | 22,187 | $4.03 | $89,469 | Indirect |
| Sep 17, 2024 | AVIR Atea Pharmaceuticals, Inc. | Sale | 33,941 | $4.05 | $137,318 | Indirect |
1-9 of 9 transactions